Protagenic Therapeutics PTIX Stock
$0.72
-2.040814%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.30M
LOW - HIGH [24H]
$0.75
-
$0.76
VOLUME [24H]
$1.20K
P/E Ratio
0.32
Earnings per share
$2.21
ISIN
US74365N3017
Protagenic Therapeutics Price Chart
Protagenic Therapeutics PTIX Financial and Trading Overview
| Protagenic Therapeutics stock price | 0.72 USD |
| Previous Close | 0.75 USD |
| Open | 0.76 USD |
| Bid | 0.72 USD x 290000 |
| Ask | 0.74 USD x 233400 |
| Day's Range | 0.75 - 0.76 USD |
| 52 Week Range | 0.13 - 3.21 USD |
| Volume | 1.2K USD |
| Avg. Volume | 13.26K USD |
| Market Cap | 1.36M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.3393665 |
| EPS (TTM) | 2.21 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PTIX Valuation Measures
| Enterprise Value | 737.18K USD |
| Trailing P/E | 0.3393665 |
| Forward P/E | -1.2931035 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.7878151 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.175 |
Trading Information
Protagenic Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -76.47% |
| S&P500 52-Week Change | 12.25% |
| 52 Week High | 3.21 USD |
| 52 Week Low | 0.13 USD |
| 50-Day Moving Average | 0.81 USD |
| 200-Day Moving Average | 0.57 USD |
PTIX Share Statistics
| Avg. Volume (3 month) | 13.26K USD |
| Avg. Daily Volume (10-Days) | 590 USD |
| Shares Outstanding | 1.81M |
| Float | 1.72M |
| Short Ratio | 0.52 |
| % Held by Insiders | 6.20% |
| % Held by Institutions | 3.68% |
| Shares Short | 50.77K |
| Short % of Float | 2.71% |
| Short % of Shares Outstanding | 2.61% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -57.30% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -4211627 USD |
| Net Income Avi to Common (ttm) | 5.46M USD |
| Diluted EPS (ttm) | 2.21 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 565.99K USD |
| Total Cash Per Share (mrq) | 0.31 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.662 |
| Book Value Per Share (mrq) | 0.952 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1999957 USD |
| Levered Free Cash Flow (ttm) | -7004950 USD |
Profile of Protagenic Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | 149 Fifth Avenue |
| ZIP | 10010 |
| Phone | 212 994 8200 |
| Website | https://www.protagenic.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
Q&A For Protagenic Therapeutics Stock
What is a current PTIX stock price?
Protagenic Therapeutics PTIX stock price today per share is 0.72 USD.
How to purchase Protagenic Therapeutics stock?
You can buy PTIX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Protagenic Therapeutics?
The stock symbol or ticker of Protagenic Therapeutics is PTIX.
Which industry does the Protagenic Therapeutics company belong to?
The Protagenic Therapeutics industry is Biotechnology.
How many shares does Protagenic Therapeutics have in circulation?
The max supply of Protagenic Therapeutics shares is 1.81M.
What is Protagenic Therapeutics Price to Earnings Ratio (PE Ratio)?
Protagenic Therapeutics PE Ratio is 0.32579187 now.
What was Protagenic Therapeutics earnings per share over the trailing 12 months (TTM)?
Protagenic Therapeutics EPS is 2.21 USD over the trailing 12 months.
Which sector does the Protagenic Therapeutics company belong to?
The Protagenic Therapeutics sector is Healthcare.
Protagenic Therapeutics PTIX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25955.34 USD — |
-0.21
|
5.73B USD — | 25866.15 USD — | 26111.62 USD — | — - | 5.73B USD — |
|
US Tech Health Care
IXHC
US
|
1327.92 USD — |
-0.97
|
— — | 1320.94 USD — | 1335.06 USD — | — - | — — |
- {{ link.label }} {{link}}
